Provided by Tiger Trade Technology Pte. Ltd.

Gossamer Bio Inc.

11.85
+0.27002.33%
Post-market: 11.50-0.3500-2.95%19:06 EDT
Volume:382.00K
Turnover:4.54M
Market Cap:72.43M
PE:-0.23
High:12.46
Open:11.53
Low:11.16
Close:11.58
52wk High:309.60
52wk Low:9.10
Shares:6.11M
Float Shares:3.83M
Volume Ratio:0.95
T/O Rate:9.99%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-51.9692
EPS(LYR):-59.6431
ROE:-783.37%
ROA:-62.39%
PB:-0.77
PE(LYR):-0.20

Loading ...

Gossamer Bio submits New Drug Application to FDA for seralutinib

TIPRANKS
·
Sep 24

Gossamer Bio Submits FDA NDA for Seralutinib in Pulmonary Arterial Hypertension

Reuters
·
Sep 24

Gossamer Bio Submits New Drug Application to U.S. FDA for Seralutinib for the Treatment of Pulmonary Arterial Hypertension

THOMSON REUTERS
·
Sep 24

Gossamer Bio, - FDA to Determine Nda Acceptance for Filing Later This Year

THOMSON REUTERS
·
Sep 24

Gossamer Bio Director Gregory Austin Ciongoli Files Initial Beneficial Ownership Statement

Reuters
·
Sep 23

Gossamer Bio, Inc. : H.c. Wainwright Adjusts Target Price to $90 to Reflect 1-for-80 Reverse Stock Split

THOMSON REUTERS
·
Sep 21

US Research Roundup-eBay, Sunbelt Rentals, T-Mobile

Reuters
·
Sep 21

Gossamer Bio Appoints Greg Ciongoli to Board, Names Him to Audit Committee

Reuters
·
Sep 17

Gossamer Bio Appoints Greg Ciongoli to Board of Directors

THOMSON REUTERS
·
Sep 17

Gossamer Bio Effects 1-for-80 Reverse Stock Split

Reuters
·
Sep 11

Gossamer Bio Announces Effectiveness of 1-for-80 Reverse Stock Split

THOMSON REUTERS
·
Sep 11

Gossamer Bio trading halted, news pending

TIPRANKS
·
Sep 11

NASDAQ Trade Halt Halt News Pending at 07:50 Pm

Reuters
·
Sep 11

Gossamer Bio Announces 1-for-80 Reverse Stock Split

THOMSON REUTERS
·
Sep 09

Gossamer Bio Highlights Seralutinib Phase 3 Prosera Data, Targets PAH NDA Filing

Reuters
·
Sep 08

Gossamer Bio to Present at Cantor Global Healthcare Conference

Reuters
·
Sep 04

Gossamer Bio - Board Approves Amendment and Restatement of Bylaws Effective Sept 3, 2026 - SEC Filing

THOMSON REUTERS
·
Sep 04

Gossamer Bio Cuts Shareholder Meeting Quorum Requirement to One-Third of Voting Power

Reuters
·
Sep 04

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Gossamer Bio (GOSS) and Biohaven Ltd. (BHVN)

TIPRANKS
·
Aug 27

NASD Most Active Issues

Dow Jones
·
Aug 22